Search research articles
Contact Us
Filters
Showing results (321-330 of 513) with videos related to
Page
of 52
Sort By:
Plos One
|
November 26, 2015
Characterisation of the Candida albicans Phosphopantetheinyl Transferase Ppt2 as a Potential Antifungal Drug Target
Katharine S Dobb, Sarah J Kaye, Nicola Beckmann, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
July 6, 2010
Effect of Kasai procedure on hepatic outcome in Alagille syndrome
Adam J Kaye, Elizabeth B Rand, Pedro S Munoz, et al.
Science (New York, N.Y.)
|
July 15, 1988
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
J W Harbour, S L Lai, J Whang-Peng, et al.
Journal of the National Cancer Institute
|
December 20, 1995
Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma
R A Kratzke, G A Otterson, C E Lincoln, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer
Sajid Khan, Lin Cao, Janet Wiegand, et al.
Clinical Radiology
|
July 2, 2003
Metastases to the breast revisited: radiological-histopathological correlation
L Bartella, J Kaye, N M Perry, et al.
International Journal of Cancer
|
October 9, 1995
CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines
M J Kelley, G A Otterson, F J Kaye, et al.
The Journal of Trauma
|
July 12, 2007
Emergency department length of stay: a major risk factor for pneumonia in intubated blunt trauma patients
Brendan G Carr, Adam J Kaye, Douglas J Wiebe, et al.
Ochsner Journal
|
July 11, 2012
Sleep physiology, abnormal States, and therapeutic interventions
Alvah T Wickboldt, Alex F Bowen, Aaron J Kaye, et al.
Cells
|
March 27, 2024
PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer
Sajid Khan, Lin Cao, Janet Wiegand, et al.
Page
of 52
Search research articles
Search
Showing results (321-330 of 513) with videos related to
Sort By:
Page
of 52
Plos One
|
November 26, 2015
Characterisation of the Candida albicans Phosphopantetheinyl Transferase Ppt2 as a Potential Antifungal Drug Target
Katharine S Dobb, Sarah J Kaye, Nicola Beckmann, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
July 6, 2010
Effect of Kasai procedure on hepatic outcome in Alagille syndrome
Adam J Kaye, Elizabeth B Rand, Pedro S Munoz, et al.
Science (New York, N.Y.)
|
July 15, 1988
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
J W Harbour, S L Lai, J Whang-Peng, et al.
Journal of the National Cancer Institute
|
December 20, 1995
Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma
R A Kratzke, G A Otterson, C E Lincoln, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer
Sajid Khan, Lin Cao, Janet Wiegand, et al.
Clinical Radiology
|
July 2, 2003
Metastases to the breast revisited: radiological-histopathological correlation
L Bartella, J Kaye, N M Perry, et al.
International Journal of Cancer
|
October 9, 1995
CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines
M J Kelley, G A Otterson, F J Kaye, et al.
The Journal of Trauma
|
July 12, 2007
Emergency department length of stay: a major risk factor for pneumonia in intubated blunt trauma patients
Brendan G Carr, Adam J Kaye, Douglas J Wiebe, et al.
Ochsner Journal
|
July 11, 2012
Sleep physiology, abnormal States, and therapeutic interventions
Alvah T Wickboldt, Alex F Bowen, Aaron J Kaye, et al.
Cells
|
March 27, 2024
PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer
Sajid Khan, Lin Cao, Janet Wiegand, et al.
Page
of 52